As of April 30, 2011, Breakthrough Chemistry Inc. carries a market capitalization of 63.31M, placing it among publicly traded companies globally. Its enterprise value stands at 63.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 63.31M |
| Enterprise Value | 63.40M |
As of April 30, 2011, Breakthrough Chemistry Inc. has 29,312.00 shares outstanding.
| Shares Outstanding | 29,312.00 |
These figures are as of April 30, 2011. The price-to-sales ratio is 131.91, and the price-to-book ratio stands at -545.70.
| PS Ratio | 131.91 |
| PB Ratio | -545.70 |
| P/TBV Ratio | -545.70 |
| P/FCF Ratio | -1,086.87 |
| P/OCF Ratio | -1,086.87 |
These figures are as of April 30, 2011. The EV/Sales ratio of 172.89 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 63.40M versus a market cap of 63.31M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 172.89 |
As of April 30, 2011, Breakthrough Chemistry Inc. maintains a current ratio of 0.81, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -76.31, indicating conservative leverage, while an interest coverage ratio of -51.54 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.81 |
| Quick Ratio | 0.10 |
| Debt / Equity | -76.31 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -51.54 |
These figures cover the twelve months ended April 30, 2011. Return on assets (ROA) is negative at -193.98, reflecting losses generated across the asset base. The company generates approximately 73,341.60 in revenue per employee across its workforce of 5.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.93 indicates how many times Breakthrough Chemistry Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -193.98 |
| Revenue Per Employee | 73,341.60 |
| Employee Count | 5.00 |
| Inventory Turnover | 0.93 |
As of the close on November 13, 2026, Breakthrough Chemistry Inc.'s stock has declined approximately 58.89% over the past 52 weeks. The 50-day moving average sits at 0.16, while the 200-day moving average is 0.18.
| 52-Week Price Change | -58.89% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.18 |
Over the twelve months ended April 30, 2011, Breakthrough Chemistry Inc. generated 366,708.00 in revenue and converted that into -1.81M in net income, yielding earnings per share of -80.63. EBITDA reached -487,406.00, while operating income came in at -491,517.00.
| Revenue | 366,708.00 |
| Gross Profit | 212,355.00 |
| Operating Income | -491,517.00 |
| Net Income | -1.81M |
| EBITDA | -487,406.00 |
| EBIT | -491,517.00 |
| Earnings Per Share (EPS) | -80.63 |
As of April 30, 2011, Breakthrough Chemistry Inc. holds 1,069.00 in cash and equivalents against 87,636.00 in total debt, resulting in a net debt position of 86,567.00. Total book value stands at -116,024.00, with working capital of -36,712.00 providing operational flexibility.
| Cash & Cash Equivalents | 1,069.00 |
| Total Debt | 87,636.00 |
| Net Debt | 86,567.00 |
| Equity (Book Value) | -116,024.00 |
| Book Value Per Share | -3.96 |
| Working Capital | -36,712.00 |
Breakthrough Chemistry Inc. produced -44,505.00 in operating cash flow over the twelve months ended April 30, 2011. After subtracting - - in capital expenditures, free cash flow totaled -44,505.00 - equivalent to -1.99 per share.
| Operating Cash Flow | -44,505.00 |
| Free Cash Flow | -44,505.00 |
| FCF Per Share | -1.99 |
Over the twelve months ended April 30, 2011, Breakthrough Chemistry Inc. posted a gross margin of 57.91, reflecting its pricing power and cost economics. The operating margin of -134.03 and net profit margin of -492.39 provide insight into operational efficiency.
| Gross Margin | 57.91 |
| Operating Margin | -134.03 |
| Profit Margin | -492.39 |
| EBITDA Margin | -132.91 |
These figures cover the twelve months ended April 30, 2011. Free cash flow yield is negative at -0.09: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.15, meaning Breakthrough Chemistry Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -0.15 |
| FCF Yield | -0.09 |
Breakthrough Chemistry Inc.'s most recent stock split took place on July 30, 2025 with a 30:1 split ratio.
| Last Split Date | 7/30/2025 |
| Split Ratio | 30:1 |
As of April 30, 2011, Breakthrough Chemistry Inc. has an Altman Z-Score of 59.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 59.99 |